Innovative Research Focus Calibr-Skaggs Institute is heavily engaged in cutting-edge translational research across multiple disease areas, providing opportunities for collaborations with biotech and pharmaceutical companies seeking advanced drug discovery platforms.

Funding Strength With a substantial funding base of over $571 million and revenue between $50 million to $100 million, the organization has robust financial resources that support extensive research initiatives and potential partnership projects.

Strategic Collaborations The institute has established partnerships with notable organizations such as Viome, the New York Stem Cell Foundation, and Xenetic Biosciences, indicating open avenues for cross-sector collaboration and co-development initiatives in biotech and biomedical research.

Technology Adoption Utilizing advanced technology stacks including Google Cloud, Hadoop, and scientific tools like SciPy and particles.js suggests a focus on data-driven research, which can be leveraged for selling cloud, analytics, or specialized scientific software solutions.

Expansion in Neuro & At-Home Testing Recent investments in neurodevelopment disorder platforms and at-home RNA screening tests for colon cancer highlight emerging market opportunities in neurotherapeutics and consumer health diagnostics, ideal for targeted sales strategies in biotech and healthcare sectors.